590 related articles for article (PubMed ID: 25677591)
1. Aptamers and their applications in nanomedicine.
Sun H; Zu Y
Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
[TBL] [Abstract][Full Text] [Related]
2. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
Guan B; Zhang X
Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
[TBL] [Abstract][Full Text] [Related]
3. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
[TBL] [Abstract][Full Text] [Related]
4. Aptamers in targeted nanotherapy.
Mathew A; Maekawa T; Sakthikumar D
Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
[TBL] [Abstract][Full Text] [Related]
5. Application of aptamers for in vivo molecular imaging and theranostics.
Bouvier-Müller A; Ducongé F
Adv Drug Deliv Rev; 2018 Sep; 134():94-106. PubMed ID: 30125606
[TBL] [Abstract][Full Text] [Related]
6. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
7. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
8. Aptamers: molecular tools for medical diagnosis.
Ozalp VC; Kavruk M; Dilek O; Bayrac AT
Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
[TBL] [Abstract][Full Text] [Related]
9. Aptamers: active targeting ligands for cancer diagnosis and therapy.
Wu X; Chen J; Wu M; Zhao JX
Theranostics; 2015; 5(4):322-44. PubMed ID: 25699094
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
11. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
12. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
[TBL] [Abstract][Full Text] [Related]
13. Antibody-targeted nanoparticles for cancer treatment.
Carter T; Mulholland P; Chester K
Immunotherapy; 2016 Jul; 8(8):941-58. PubMed ID: 27381686
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
[TBL] [Abstract][Full Text] [Related]
16. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
[TBL] [Abstract][Full Text] [Related]
18. Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.
Lao YH; Phua KK; Leong KW
ACS Nano; 2015 Mar; 9(3):2235-54. PubMed ID: 25731717
[TBL] [Abstract][Full Text] [Related]
19. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
20. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
